Improving the prognosis of cryptococcosis relies upon three factors, and first, the control of the underlying immunodeficiency [20], [21] as shown by the beneficial effect of HAART (with the remaining question of the best timing for its introduction [22]), and preliminary results obtained with administration of gamma interferon or monoclonal antibodies [23], [24]. The gene discussed is IFNG; the disease is cryptococcosis.